Risk of Community-Acquired Pneumonia in Veteran Patients to Whom Proton Pump Inhibitors Were Dispensed
Open Access
- 18 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (1), 33-42
- https://doi.org/10.1093/cid/cir767
Abstract
Background. Observational studies linking proton pump inhibitor (PPI) exposure with community-acquired pneumonia (CAP) have reported either modest or no associations. Accordingly, we studied PPI exposure and CAP in veteran patients, using a retrospective, nested case-control design. Methods. From linked pharmacy and administrative databases of the New England Veterans Healthcare System, we identified 71985 outpatients newly prescribed PPIs between 1998 and 2007; 1544 patients met criteria for CAP subsequent to PPI initiation; 15440 controls were matched through risk-set sampling by age and time under observation. Crude and adjusted odds ratios comparing current with past PPI exposures, as well as tests for interactions, were conducted for the entire and stratified samples. Results. Current PPI use associated with CAP (adjusted odds ratio [OR], 1.29 [95% confidence interval {CI}, 1.15–1.45]). Risks were not substantially altered by age or year of diagnosis. Dementia (n = 85; P = .062 for interaction) and sedative/tranquilizer use (n = 224; P = .049 for interaction) were likely effect modifiers increasing a PPI-CAP association; conversely, for some chronic medical conditions, PPI-associated CAP risks were reversed. PPI exposures between 1 and 15 days increased CAP risks, compared with longer exposures, but PPI initiation also frequently occurred shortly after CAP diagnoses. Prescribed PPI doses >1 dose/day also increased PPI-associated CAP risks. Conclusions. Among the veterans studied, current compared with past PPI exposures associated modestly with increased risks of CAP. However, our observations that recent treatment initiation and higher PPI doses were associated with greater risks, and the inconsistent PPI-CAP associations between patient subgroups, indicate that further inquiries are needed to separate out coincidental patterns of associations.Keywords
This publication has 31 references indexed in Scilit:
- Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control studyPharmacoepidemiology and Drug Safety, 2010
- Pharmacotherapy and the risk for community-acquired pneumoniaBMC Geriatrics, 2010
- Acid-Suppressive Medication Use and the Risk for Hospital-Acquired PneumoniaJAMA, 2009
- Risk of community‐acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population‐based case–control studyPharmacoepidemiology and Drug Safety, 2009
- Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving EsomeprazoleDrug Safety, 2008
- Association between Proton Pump Inhibitor Use and Spontaneous Bacterial PeritonitisDigestive Diseases and Sciences, 2007
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of Internal Medicine, 2007
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcerDigestive Diseases and Sciences, 1996
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995